Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Aug;50(2):227–230. doi: 10.1038/bjc.1984.167

Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.

B Tank, R L Marquet, W Weimar, D L Westbroek
PMCID: PMC1976876  PMID: 6466539

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Einhorn S., Blomgren H., Strander H. Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int J Cancer. 1978 Oct 15;22(4):405–412. doi: 10.1002/ijc.2910220407. [DOI] [PubMed] [Google Scholar]
  2. Einhorn S., Blomgren H., Strander H. Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon. Int J Cancer. 1980 Oct 15;26(4):419–428. doi: 10.1002/ijc.2910260406. [DOI] [PubMed] [Google Scholar]
  3. Gresser I., De Maeyer-Guignard J., Tovey M. G., De Maeyer E. Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5308–5312. doi: 10.1073/pnas.76.10.5308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Herberman R. R., Ortaldo J. R., Bonnard G. D. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature. 1979 Jan 18;277(5693):221–223. doi: 10.1038/277221a0. [DOI] [PubMed] [Google Scholar]
  5. Huddlestone J. R., Merigan T. C., Jr, Oldstone M. B. Induction and kinetics of natural killer cells in humans following interferon therapy. Nature. 1979 Nov 22;282(5737):417–419. doi: 10.1038/282417a0. [DOI] [PubMed] [Google Scholar]
  6. Lotzová E., Savary C. A., Gutterman J. U., Hersh E. M. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha. Cancer Res. 1982 Jun;42(6):2480–2488. [PubMed] [Google Scholar]
  7. Maluish A. E., Ortaldo J. R., Conlon J. C., Sherwin S. A., Leavitt R., Strong D. M., Weirnik P., Oldham R. K., Herberman R. B. Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J Immunol. 1983 Jul;131(1):503–507. [PubMed] [Google Scholar]
  8. Oehler J. R., Herberman R. B. Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid. Int J Cancer. 1978 Feb 15;21(2):221–229. doi: 10.1002/ijc.2910210214. [DOI] [PubMed] [Google Scholar]
  9. Ortaldo J. R., Bonnard G. D., Herberman R. B. Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol. 1977 Oct;119(4):1351–1357. [PubMed] [Google Scholar]
  10. Saksela E., Timonen T., Cantell K. Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells. Scand J Immunol. 1979;10(3):257–266. doi: 10.1111/j.1365-3083.1979.tb01348.x. [DOI] [PubMed] [Google Scholar]
  11. Skurkovich S. V., Skorikova A. S., Eremkina E. I. Enhancement by interferon of lymphocyte cytotoxicity in normal individuals to cells of human lymphoblastoid lines. J Immunol. 1978 Sep;121(3):1173–1176. [PubMed] [Google Scholar]
  12. Staehelin T., Hobbs D. S., Kung H., Lai C. Y., Pestka S. Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. J Biol Chem. 1981 Sep 25;256(18):9750–9754. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES